Editorial comment from Dr Yuasa to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma

Detalles Bibliográficos
Autor principal: Yuasa, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Editorial Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609186/
https://www.ncbi.nlm.nih.gov/pubmed/33163929
http://dx.doi.org/10.1002/iju5.12228
_version_ 1783604975260139520
author Yuasa, Takeshi
author_facet Yuasa, Takeshi
author_sort Yuasa, Takeshi
collection PubMed
description
format Online
Article
Text
id pubmed-7609186
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-76091862020-11-06 Editorial comment from Dr Yuasa to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma Yuasa, Takeshi IJU Case Rep Editorial Comment John Wiley and Sons Inc. 2020-10-07 /pmc/articles/PMC7609186/ /pubmed/33163929 http://dx.doi.org/10.1002/iju5.12228 Text en © 2020 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial Comment
Yuasa, Takeshi
Editorial comment from Dr Yuasa to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma
title Editorial comment from Dr Yuasa to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma
title_full Editorial comment from Dr Yuasa to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma
title_fullStr Editorial comment from Dr Yuasa to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma
title_full_unstemmed Editorial comment from Dr Yuasa to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma
title_short Editorial comment from Dr Yuasa to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma
title_sort editorial comment from dr yuasa to pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma
topic Editorial Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609186/
https://www.ncbi.nlm.nih.gov/pubmed/33163929
http://dx.doi.org/10.1002/iju5.12228
work_keys_str_mv AT yuasatakeshi editorialcommentfromdryuasatopathologicalcompleteresponseafternivolumabtherapyfollowingangiogenesisinhibitorsinapatientwithmetastaticrenalcellcarcinoma

Ejemplares similares